Vanda Pharmaceuticals (VNDA) Share-based Compensation (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.17% |
| Dec 31, 2025 | 8.19% |
| Sep 30, 2025 | 0.28% |
| Jun 30, 2025 | -29.11% |
| Mar 31, 2025 | 3.77% |
| Dec 31, 2024 | -4.53% |
| Sep 30, 2024 | 0.44% |
| Jun 30, 2024 | -16.69% |
| Mar 31, 2024 | 9.50% |
| Dec 31, 2023 | 3.35% |
| Sep 30, 2023 | -2.52% |
| Jun 30, 2023 | -25.33% |
| Mar 31, 2023 | 15.01% |
| Dec 31, 2022 | -2.70% |
| Sep 30, 2022 | 1.51% |
| Jun 30, 2022 | -19.84% |
| Mar 31, 2022 | 26.60% |
| Dec 31, 2021 | -4.48% |
| Sep 30, 2021 | 5.64% |
| Jun 30, 2021 | -4.32% |
| Mar 31, 2021 | 21.70% |
| Dec 31, 2020 | 2.46% |
| Sep 30, 2020 | 2.15% |
| Jun 30, 2020 | -22.19% |
| Mar 31, 2020 | 7.52% |
| Dec 31, 2019 | 7.66% |
| Sep 30, 2019 | 9.87% |
| Jun 30, 2019 | -5.51% |
| Mar 31, 2019 | 12.32% |
| Dec 31, 2018 | 1.74% |
| Sep 30, 2018 | 5.55% |
| Jun 30, 2018 | -13.65% |
| Mar 31, 2018 | 13.26% |
| Dec 31, 2017 | 0.40% |
| Sep 30, 2017 | 4.33% |
| Jun 30, 2017 | 17.73% |
| Mar 31, 2017 | 7.28% |
| Dec 31, 2016 | 0.14% |
| Sep 30, 2016 | 1.25% |
| Jun 30, 2016 | -8.47% |
| Mar 31, 2016 | 20.08% |
| Dec 31, 2015 | -8.44% |
| Sep 30, 2015 | -0.34% |
| Jun 30, 2015 | 6.32% |
| Mar 31, 2015 | 19.25% |
| Dec 31, 2014 | 15.59% |
| Sep 30, 2014 | -2.22% |
| Jun 30, 2014 | 3.59% |
| Mar 31, 2014 | -4.39% |
| Dec 31, 2013 | -5.14% |
| Sep 30, 2013 | 38.75% |
| Jun 30, 2013 | -15.11% |
| Mar 31, 2013 | -30.49% |
| Dec 31, 2012 | 225.69% |
| Sep 30, 2012 | -51.52% |
| Jun 30, 2012 | -14.59% |
| Mar 31, 2012 | 5.54% |
| Dec 31, 2011 | 5.10% |
| Sep 30, 2011 | -5.36% |
| Jun 30, 2011 | -17.39% |
| Mar 31, 2011 | 20.15% |
| Dec 31, 2010 | 50.51% |